HIRAMATSU Naoki 平松直樹

Researcher Number	30362700
Other IDs
Affiliation (based on the past Project Information) *help	2015: 大阪大学, 医学(系)研究科(研究院), 准教授 2012 – 2014: 大阪大学, 医学(系)研究科(研究院), 講師 2012: 大阪大学, 大学院・医学系研究科, 講師 2008 – 2011: 大阪大学, 医学系研究科, 講師 2007 – 2008: Osaka University, Graduate School of Medicine, Assistant Professor … More 2005 – 2006: 大阪大学, 医学系研究科, 助手 2004: 大阪大学, 医学系研究科, 寄附講座助手 2003: Osaka University Graduate School of Medicine, Assistant Professor, 医学系研究科, 寄附講座教員 Less
Review Section/Research Field	Principal Investigator Gastroenterology Except Principal Investigator Gastroenterology / Gastroenterology
Keywords	Principal Investigator ELISPOT / CTL / Interferon therapy / Immuno-monitoring / Chronic hepatitis type C / インターフェロン / ELISPOT法 / インターフェロン治療 / 免疫モニタリング / C型慢性肝炎 … More / Deep sequence法 / シメプレビル / 次世代シークエンサー / HCV遺伝子多型 / DAA治療 / C型肝炎 / 薬剤耐性変異 / メタボリックシンドローム / 小胞体ストレス / ERストレス / MCP-1 / NASH / GnT-V / 脂肪肝 / 糖鎖 / 肝臓学 … More Except Principal Investigator RIG-I / 樹状細胞 / リバビリン / MICA / NK細胞 / 肝癌 / 制御性T細胞 / C型肝炎 / MICB / NKG2D / Toll-like receptor / NK receptor / Th1 / NKレセプター / 自然免疫 / 肝がん / natural killer cell / 獲得免疫 / 先天免疫 / IFNα / インターフェロンα / Toll様受容体 / ペグインターフェロンα / 肝臓 / Relaxed-circular (RC) HBV DNA / HBV mutation / Hepatitis B virus (HBV) / 環状2本鎖(RC)HBV DNA / HBV変異 / B型肝炎ウイルス(HBV) / Innate immunity / Tumor / Liver / HCC / Soluble MICB / Soluble MICA / 自然免 / TAE / 肝硬変 / Regulatory T cells / Ribavirin / Pegylated interferon-a / Dendritic cells / Chronic hepatitis C / Th2 / C型慢性肝炎 / innate immuni / dendritic cell / hepatocellular carcinoma / chronic hepatitis C / IL-15 / Pseudo-HCV / サブセット / B / blood DC / 免疫 / IL-10 / FoxP3 / 持続ALT正常 / ペグインターフェロン / regulatory T細胞 / インターフェロン / Toll様レセプター / tumor / innate immunity / interferon α / interleukin-12 / α-galactosyl ceramide / liver / cancer / natural killer T cell / 抗腫瘍免疫 / IFN_γ / CDld / α-GalCer / 腫瘍 / 遺伝子治療 / 腫瘍免疫 / IL-12 / NKT細胞 / トリプトファン / キヌレニン / IDO / HCV / 骨髄系前駆細胞 / TIE2 / 血管新生 / Type III IFN / HCVプロテアーゼ阻害剤 / 性差 / 抗ウイルス治療 / マウス / 遺伝子導入 / IFN / B型肝炎 / Precore変異 / YMDD変異 / 酵素阻害剤 / 遺伝子解析 / 耐性ウイルス / ラミブジン / HBV Less

The relationship between the efficacy and the prevalence of the mutant virus for the novel anti-viral drugs for hepatitis CPrincipal Investigator
- Principal Investigator
  
  hiramatsu naoki
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Development of novel therapy for hepatocellular carcinoma targeting of bone marrow-derived angiogenesis precursor
- Principal Investigator
  
  KANTO Tatsuya
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Investigation for the mechanisms of immune tolerance against HCV mediated by tryptophan-catalyzing enzyme, IDO
- Principal Investigator
  
  KASAHARA Akinori
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Analysis of NASH pathophysiology using glycobiological techniquePrincipal Investigator
- Principal Investigator
  
  HIRAMATSU Naoki, MATSUMOTO Hitoshi
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Developmental research of tailored immune-modulation therapy against refractory chronic hepatitis C.
- Principal Investigator
  
  KASAHARA Akinori
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Developmental research on dendritic cell-based immunotherapy against chronic hepatitis C and hepatocellular carcinoma
- Principal Investigator
  
  KANTO Tatsuya
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Molecular regulation of NK cell cytotoxicity fir human hepatocellular carcinoma
- Principal Investigator
  
  TAKEHARA Tetsuo
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Hepatitis B virus mutations affecting synthesis of relaxed-circular viral DNA : Relation to disease severity
- Principal Investigator
  
  OHKAWA Kazuyoshi
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
HBV遺伝子導入マウスでの酵素阻害剤誘発変異の解析とテーラーメイド医療への応用
- Principal Investigator
  
  TAKEHARA Tetsuo
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Exploratory Research
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
CTL immuno-monitoring in chronic hepatitis CPrincipal Investigator
- Principal Investigator
  
  HIRAMATSU Naoki
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Establishment of plasmacytoid dendritic cell-based immune therapy against viral hepatitis and hepatocellular carcinoma
- Principal Investigator
  
  KANTO Tatsuya
- Project Period (FY)
  2004 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Regulation of dendritic cell function and cell-based therapy in chronic hepatitis C virus infection
- Principal Investigator
  
  HAYASHI Norio
- Project Period (FY)
  2003 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (S)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Suppression of hepatocarcinogenesis by activating natural killer T cells
- Principal Investigator
  
  TAKEHARA Tetsuo
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University

All 2016 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 Other

All Journal Article Presentation

[Journal Article] Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients.2014
- Author(s)
  Yamada R, Hiramatsu N, Oze T, Morishita N, Harada N, Miyazaki M, Yakushijin T, Miyagi T, Yoshida Y, Tatsumi T, Kanto T, Hayashi N, Takehara T.
- Journal Title
  
  J Med Virol.
  
  Volume: 86 Issue: 2 Pages: 241-7
- DOI
  10.1002/jmv.23840
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25460994, KAKENHI-PROJECT-26461001, KAKENHI-PROJECT-26860503
[Journal Article] Risk factors for hepatocellular carcinoma in hepatitis C patients with normal ALT treated with pegylated interferon and ribavirin2014
- Author(s)
  Harada N, Hiramatsu N, Oze T, Morishita N, Yamada R, Hikita H, Miyazaki M, Yakushijin T, Miyagi T, Yoshida Y, Tatsumi T, Kanto A, Kasahara A, Oshita M, Mita E, Hagiwara H, Inui Y, Katayama K, Shinji Tamura, Yoshihara H, Imai Y, Inoue A, Hayashi N, Takehara T
- Journal Title
  
  J Viral Hepat
  
  Volume: ２１ Issue: 5 Pages: 357-365
- DOI
  10.1111/jvh.12151
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24590973, KAKENHI-PROJECT-24590975, KAKENHI-PROJECT-25460994, KAKENHI-PROJECT-26860503
[Journal Article] Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus2013
- Author(s)
  Yoshio S, Kanto T, Kuroda S, Matsubara T, Higashitani K, Kakita N, Ishida H, Hiramatsu N, Nagano H, Sugiyama M, Murata K, Fukuhara T, Matsuura Y, Hayashi N, Mizokami M, Takehara T
- Journal Title
  
  Hepatology
  
  Volume: 57 Issue: 5 Pages: 1705-15
- DOI
  10.1002/hep.26182
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390117, KAKENHI-PROJECT-23591005, KAKENHI-PROJECT-25460994, KAKENHI-PROJECT-25860574
[Journal Article] TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlated with angiogenesis2013
- Author(s)
  Matsubara, T., Kanto, T., Kuroda, S., Yoshio, S., Higashitani, K., Kakita, N., Miyazaki, M., Sakakibara, M., Hiramatsu, N., Kasahara, A., Tomimaru, Y., Tomokuni, A., Nagano, H., Hayashi, N. and Takehara, T.
- Journal Title
  
  Hepatology
  
  Volume: 57 Pages: 1416-1425
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] The Bcl-2 homology 3 (BH3)-only proteins Bim and Bid are functionally active and restrained by anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) family proteins in healthy liver.2013
- Author(s)
  [1] Kodama T, Hikita H, Kawaguchi T, Saito Y, Tanaka S, Shigekawa M, Shimizu S, Li W, Miyagi T, Kanto T, Hiramatsu N, Tatsumi T, Takehara T.
- Journal Title
  
  J. Biol. Chem.
  
  Volume: 288 Issue: 42 Pages: 30009-30018
- DOI
  10.1074/jbc.m112.443093
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390197, KAKENHI-PROJECT-24590970, KAKENHI-PROJECT-24590973, KAKENHI-PROJECT-24790694, KAKENHI-PROJECT-25460994
[Journal Article] Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection2013
- Author(s)
  Higashitani, K., Kanto, T., Kuroda, S., Yoshio, S., Matsubara, T., Kakita, N., Oze, T., Miyazaki, M., Sakakibara, M., Hiramatsu, N., Mita, E., Imai, Y., Kasahara, A., Okuno, A., Takikawa, O., Hayashi, N. and Takehara, T.
- Journal Title
  
  J Gastroenterol
- NAID
  10031177017
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Carbamazepine promotes liver regeneration and survival in mice.2013
- Author(s)
  Kawaguchi T, Kodama T, Hikita H, Tanaka S, Shigekawa M, Nawa T, Shimizu S, Li W, Miyagi T, Hiramatsu N, Tatsumi T, Takehara T.
- Journal Title
  
  J Hepatol.
  
  Volume: 59 Issue: 6 Pages: 1239-1245
- DOI
  10.1016/j.jhep.2013.07.018
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24790694, KAKENHI-PROJECT-25460994
[Journal Article] the Osaka Liver Forum. Post-treatment Levels ofα-fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy2013
- Author(s)
  Oze T, Yoshida Y,他25人
- Journal Title
  
  Clin Gastroenterol Hepatol
  
  Volume: (Epub ahead of print), (pii : S1542-3565(13)01840-5) Issue: 7 Pages: 1239-45
- DOI
  10.1016/j.cgh.2013.11.033
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590974, KAKENHI-PROJECT-24590973, KAKENHI-PROJECT-25460994, KAKENHI-PROJECT-26461001, KAKENHI-PROJECT-26860503
[Journal Article] Incidence of hepatocellular carcinoma in HCV -infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines2013
- Author(s)
  Harada, N., Hiramatsu, N., Oze, T., Yamada, R., Kurokawa, M., Miyazaki, M., Yakushijin, T., Miyagi, T., Tatsumi, T., Kiso, S., Kanto, T., Kasahara, A., Oshita, M., Mita, E., Hagiwara, H., Inui, Y., Katayama, K., Tamura, S., Yoshihara, H., Imai, Y., Inoue
- Journal Title
  
  J Gastroenterol
- NAID
  10031169228
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.2013
- Author(s)
  Kamada Y, Akita M, Takeda Y, Yamada S, Fujii H, Sawai Y, Doi Y, Asazawa H, Nakayama K, Mizutani K, Fujii H, Yakushijin T, Miyazaki M, Ezaki H, Hiramatsu N, Yoshida Y, Kiso S, Imai Y, Kawada N, Takehara T, Miyoshi E.
- Journal Title
  
  PLoS One.
  
  Volume: 8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460994
[Journal Article] Valine, the branched-chain amino acid, suppresses hepatitis C virus RNA replication but promotes infectious particle formation2013
- Author(s)
  Ishida H, Kato T, Takehana K, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 437 Issue: 1 Pages: 127-33
- DOI
  10.1016/j.bbrc.2013.06.051
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590973, KAKENHI-PROJECT-24790694, KAKENHI-PROJECT-25460994
[Journal Article] The combination therapy of α-galactosylceramide and 5-fluorouracil showed antitumor effect synergistically against liver tumor in mice2013
- Author(s)
  Aketa H, Tatsumi T, Kohga K, Tsunematsu H, Aono S, Shimizu S, Kodama T, Nawa T, Shigekawa M, Hikita H, Sakamori R, Hosui A, Miyagi T, Hiramatsu N, Kanto T, Hayashi N, Takehara T
- Journal Title
  
  Int J Cancer
  
  Volume: 133 Issue: 5 Pages: 1126-34
- DOI
  10.1002/ijc.28118
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590973, KAKENHI-PROJECT-24790694, KAKENHI-PROJECT-25460994
[Journal Article] Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.2012
- Author(s)
  Kanto, T., Inoue, M., Oze, T., Miyazaki, M., Sakakibara, M., Kakita, N., Matsubara, T., Higashitani, K., Hagiwara, H., Iio, S., Katayama, K., Mita, E., Kasahara, A., Hiramatsu, N., Takehara, T. and Hayashi, N
- Journal Title
  
  J Gastroenterol
  
  Volume: 47 Pages: 169-178
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells2012
- Author(s)
  Kakita, N., Kanto, T., Itose, I., Kuroda, S., Inoue, M., Matsubara, T., Higashitani, K., Miyazaki, M., Sakakibara, M., Hiramatsu, N., Takehara, T., Kasahara, A. and Hayashi, N
- Journal Title
  
  Int J Cancer
  
  Volume: 31 Pages: 2573-2583
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.2012
- Author(s)
  Kanto, T. *, Inoue, M., Oze, T., Miyazaki, M., Sakakibara, M., Kakita, N., Matsubara, T., Higashitani, K., Hagiwara, H., Iio, S., Katayama, K., Mita, E., Kasahara, A., Hiramatsu, N., Takehara, T. and Hayashi, N.
- Journal Title
  
  J Gastroenterol
  
  Volume: 47 Pages: 169-178
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin2012
- Author(s)
  Oze, T., Hiramatsu, N., Song, C., Yakushijin, T., Iio, S., Doi, Y., Oshita, M., Hagiwara, H., Mita, E., Ito, T., Inui, Y., Hijioka, T., Tamura, S., Yoshihara, H., Inoue, A., Imai, Y., Hayashi, E., Kato, M., Miyazaki, M., Hosui, A., Miyagi, T., Yoshida, Y.
- Journal Title
  
  J Gastroenterol
  
  Volume: 47 Pages: 334-342
- NAID
  10030560255
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.2012
- Author(s)
  Tsunematsu, H., Tatsumi, T., Kohga, K., Yamamoto, M., Aketa, H., Miyagi, T., Hosui, A., Hiramatsu, N., Kanto, T., Hayashi, N. and Takehara, T
- Journal Title
  
  Int J Cancer
  
  Volume: 130 Pages: 356-364
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.2011
- Author(s)
  Oze T, Hiramatsu N(2番目), et. al.
- Journal Title
  
  J Hepatol 54(4)
  
  Pages: 604-11
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan2011
- Author(s)
  Oze, T., Hiramatsu, N., et al
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 46 Pages: 944-952
- NAID
  10029313419
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] The efficacy of exten ded treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan.2011
- Author(s)
  Oze, T., Hiramatsu, N., Yakushijin, T., Mochizuki, K., Imanaka, K., Yamada, A., Oshita, M., Kaneko, A., Hagiwara, H., Mita, E., Ito, T., Nagase, T., Inui, Y., Hijioka, T., Tamura, S., Yoshihara, H., Hayashi, E., Imai, Y., Kato, M., Hosui, A., Miyagi, T.
- Journal Title
  
  J Gastroenterol
  
  Volume: 46 Pages: 944-952
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.2011
- Author(s)
  Shimizu, S., Takehara, T., Hikita, H., Kodama, T., Tsunematsu, H., Miyagi, T., Hosui, A., Ishida, H., Tatsumi, T., Kanto, T., Hiramatsu, N., Fujita, N., Yoshimori, T. and Hayashi, N
- Journal Title
  
  Int J Cancer
  
  Volume: 131 Pages: 548-557
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.2011
- Author(s)
  Oze, T., Hiramatsu, N., Yakushijin, T., Mochizuki, K., Oshita, M., Hagiwara, H., Mita, E., Ito, T., Fukui, H., Inui, Y., Hijioka, T., Inada, M., Kaytayama, K., Tamura, S., Yoshihara, H., Inoue, A., Imai, Y., Kato, M., Miyagi, T., Yoshida, Y., Tatsumi, T.
- Journal Title
  
  J Hepatol
  
  Volume: 54 Pages: 604-611
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan.2011
- Author(s)
  Oze T, Hiramatsu N(2番目), et. al.
- Journal Title
  
  J Gastroenterol in press
- NAID
  10029313419
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin2011
- Author(s)
  Inoue Y, Tatsumi T, et al
- Journal Title
  
  Journal of Medical Virology
  
  Volume: 83 Issue: 3 Pages: 419-427
- DOI
  10.1002/jmv.21975
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590841, KAKENHI-PROJECT-22590730, KAKENHI-PROJECT-23590974
[Journal Article] Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide2011
- Author(s)
  Sakakibara, M., Kanto, T., Hayakawa, M., Kuroda, S., Miyatake, H., Itose, I., Miyazaki, M., Kakita, N., Higashitani, K., Matsubara, T., Hiramatsu, N., Kasahara, A., Takehara, T.and Hayashi, N
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 60 Pages: 1565-1575
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated by peginterferon and ribavirin therapy.2011
- Author(s)
  Inoue Y, Hiramatsu N(2番目), et. al.
- Journal Title
  
  J Med Virol 83(3)
  
  Pages: 419-27
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan2011
- Author(s)
  Oze, T., Hiramatsu, N., et al
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 46 Pages: 1031-1037
- NAID
  10029563329
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated withpeginterferon and ribavirin.2011
- Author(s)
  Inoue, Y., Hiramatsu, N., Oze, T., Yakushijin, T., Mochizuki, K., Fukuda, K., Mita, E., Haruna, Y ., Inoue, A., Imai, Y., Hosui, A., Miyagi, T., Yoshida, Y., Tatsumi, T., Kiso, S., Kanto, T., Kasahara, A., Takehara, T. and Hayashi, N. *
- Journal Title
  
  J Med Virol
  
  Volume: 83 Pages: 419-427
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] alpha-Galactosylceramide activates antitumor immunity against liver tumor.2011
- Author(s)
  Tatsumi, T., Takehara, T., Miyagi, T., Sugiyama, T., Aketa, H., Sasakawa, A., Kanto, T., Hiramatsu, N. and Hayashi, N
- Journal Title
  
  Hepatol Res
  
  Volume: 41 Pages: 160-169
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan2011
- Author(s)
  Oze, T., Hiramatsu, N., Yakushijin, T., Mochizuki, K., Oshita, M., Hagiwara, H., Mita, E., Ito, T., Inui, Y., Fukui, H., Hijioka, T., Katayama, K., T amura, S., Yoshihara, H., Inoue, A., Imai, Y., Hayashi, E., Kato, M., Hosui, A., Miyagi, T., Ishida, H.
- Journal Title
  
  J Gastroenterol
  
  Volume: 46 Pages: 1031-1037
- NAID
  10029563329
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.2011
- Author(s)
  Oze, T., Hiramatsu, N., et al.
- Journal Title
  
  J Hepatol
  
  Volume: (印刷中)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated by peginterferon and ribavirin therapy.2011
- Author(s)
  Inoue Y, Hiramatsu N, et al.
- Journal Title
  
  J Med Virol.
  
  Volume: 83(3) Pages: 419-27
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin.2011
- Author(s)
  Inoue, Y., Hiramatsu, N., et al.
- Journal Title
  
  J Med Virol
  
  Volume: 83 Pages: 419-427
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.2011
- Author(s)
  Hiramatsu, N., Inoue, Y., Oze, T., Kurashige, N., Yakushijin, T., Mochizuki, K., Miyagi, T., Tatsumi, T., Kiso, S., Kanto, T., Kasahara, A., Takehara, T., Oshita, M., Mita, E., Hagiwara, H., Inui, Y., Katayama, K., Tamura, S., Yoshihara, H., Imai, Y. and
- Journal Title
  
  J Gastroenterol
  
  Volume: 46 Pages: 1335-1343
- NAID
  10030295018
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] and Hayashi, N., Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin2011
- Author(s)
  Inoue, Y., Hiramatsu, N., Oze, T., Yakushijin, T., Mochizuki, K., Fukuda, K., Mita, E., Haruna, Y., Inoue, A., Imai, Y., Hosui, A., Miyagi, T., Yoshida, Y., Tatsumi, T., Kiso, S., Kanto, T., Kasahara, A., Takehara, T
- Journal Title
  
  J Med Virol
  
  Volume: 83 Pages: 419-427
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.2011
- Author(s)
  Oze T, Hiramatsu N, et al.
- Journal Title
  
  J Hepatol.
  
  Volume: (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy2011
- Author(s)
  Oze, T., Hiramatsu, N, et al
- Journal Title
  
  Journal of Hepatology
  
  Volume: 54 Pages: 604-611
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study2011
- Author(s)
  Hiramatsu, N., Inoue, Y., et al
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 46 Pages: 1335-1343
- NAID
  10030295018
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Pretreatment Prediction of Anemia Progression by Pegylated interferon Alpha-2b Plus Ribavirin Combination Therapy in Chronic Hepatitis C Infection : Decision-Tree Analysis.2011
- Author(s)
  Hiramatsu N(1番目), Kurosaki M, et. al.
- Journal Title
  
  J Gastroenterol in press
- NAID
  10029706983
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] nvolvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice2011
- Author(s)
  Shigekawa, M., Takehara, T., Kodama, T., Hikita, H., Shimizu, S., Li, W., Miyagi, T., Hosui, A., Tatsumi, T., Ishida, H., Kanto, T., Hiramatsu, N. and Hayashi, N
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 406 Pages: 614-620
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan.2011
- Author(s)
  Oze T, Hiramatsu N(2番目), et. al.
- Journal Title
  
  J Gastroenterol in press
- NAID
  10029563329
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection2010
- Author(s)
  Miyagi, T., Takehara, T. *, Nishio, K., Shimizu, S., Kohga, K., Li, W., Tatsumi, T., Hiramatsu, N., Kanto, T. and Hayashi, N.
- Journal Title
  
  J Hepatol
  
  Volume: 53 Pages: 424-430
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin : reducing drug doses has no impact on rapid and sustained virological responses.2010
- Author(s)
  Inoue Y, Hiramatsu N(2番目), et. al.
- Journal Title
  
  J Viral Hepat 17(5)
  
  Pages: 336-44
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin : reducing drug doses has no impact on rapid and susutained virological responses.2010
- Author(s)
  Inoue, Y., Hiramatsu, N., et al.
- Journal Title
  
  J Viral Hepatitis
  
  Volume: 17 Pages: 336-344
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590730
[Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin : reducing drug doses has no impact on rapid and sustained virological responses.2010
- Author(s)
  Inoue Y, Hiramatsu N, et al.
- Journal Title
  
  J Viral Hepat.
  
  Volume: 17(5) Pages: 336-44
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.2010
- Author(s)
  Hikita H, Hiramatsu N(13番目), et. al.
- Journal Title
  
  Hepatology 52(4)
  
  Pages: 1310-21
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.2010
- Author(s)
  Hikita H, Hiramatsu N, et al.
- Journal Title
  
  Hepatology
  
  Volume: 52(4) Pages: 1310-21
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet.2010
- Author(s)
  Miyagi, T., Takehara, T., Uemura, A., Nishio, K., Shimizu, S., Kodama, T., Hikita, H., Li, W., Sasakawa, A., Tatsumi, T., Ohkawa, K., Kanto, T., Hiramatsu, N. and Hayashi, N
- Journal Title
  
  J Gastroenterol
  
  Volume: 45 Pages: 1247-1254
- NAID
  10027700169
- Data Source
  KAKENHI-PROJECT-22590729
[Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and susutained virological responses.2009
- Author(s)
  Inoue, Y., Hiramatsu, N, Oze, T., Yakushijin, T., Mochizuki, K., Hagiwara, H., Oshita, M., Mita, E., Fukui, H., Inada, M., Tamura, S., Yoshihara, H., Hyashi, E., Inoue, A., Imai, Y., Kato, M., Miyagi, T., Hohsui, A., Ishida, M., Kiso, S., Kanto, T., Kasahara, A., Takehara, T., Hayashi, N.
- Journal Title
  
  Journal of Viral Hepatitis (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2b plus ribavirin2009
- Author(s)
  Hiramatsu N, Oze T, et al.
- Journal Title
  
  J Viral Hepat. 16(8)
  
  Pages: 586-94
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.2009
- Author(s)
  Kohga, K., Takehara, T. Tatsumi, T., Miyagi, T., Ishida, H., Ohkawa, K., Kanto, T., Hiramatsu, N., Hayashi, N.
- Journal Title
  
  Cancer Resarch 69
  
  Pages: 8050-8057
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Peginterferon, alfa-2b affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with pegylated interferon alfa-2b plus ribavirin2009
- Author(s)
  Oze T, Hiramatsu N, et al.
- Journal Title
  
  J Viral Hepat. 16(8)
  
  Pages: 578-85
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis.2009
- Author(s)
  Kurokawa M, Hiramatsu N(2番目), et. al.
- Journal Title
  
  Hepatol Res 39(5)
  
  Pages: 432-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2b plus ribavirin.2009
- Author(s)
  Hiramatsu N(1番目), Oze T, et. al.
- Journal Title
  
  J Viral Hepat 16(8)
  
  Pages: 586-94
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.2009
- Author(s)
  Itose, I., Kanto, T. Kakita, N., Takebe, S., Inoue, M., Higashitani, K., Miyazaki, M., Miyatake, H., Sakakibara, M., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Viral Hepatitis 16
  
  Pages: 846-852
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir2009
- Author(s)
  Kurashige N, Hiramatsu N, et al.
- Journal Title
  
  Antivir Ther. 14(6)
  
  Pages: 873-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.2009
- Author(s)
  Hiramatsu, N., Oze, T Yakushijin, T., Inoue, Y., Igura, T., Mochizuki, K., Imanaka, K., Kaneko, A., Oshita, M., Hagiwara, H., Mita, E., Nagase, T., Ito, T., Inui, Y., Hijioka, T., Katayama, K., Tamura, S., Yoshihara, H., Imai, Y., Kato, M., Yoshida, Y., Tatsumi, T., Ohkawa, K., Kiso, S., Kanto, T., Kasahara, A., Takehara, T., Hayashi, N.
- Journal Title
  
  Journal of Viral Hepatitis 16
  
  Pages: 586-594
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders2009
- Author(s)
  Imai, Y., Tamura, S.,. Tanaka, H., Hiramatsu, N., Kiso, Y., Doi, Y., Inada, M., Nagase, T., Kitada, T., Imanaka, K., Fukuda, K., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Viral Hepatitis (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver.2009
- Author(s)
  Hikita H, Takehara T., Shimizu, S., Kodama, T., Li, W., Miyagi, T., Hosui, A., Ishida, H., Ohkawa, K., Kanto, T., Hiramatsu, N., Yin, X.M., Hennighausen, L., Tatsumi, T., Hayashi, N.
- Journal Title
  
  Hepatology 16
  
  Pages: 1217-1226
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and susutained virological responses2009
- Author(s)
  Inoue, Y., Hiramatsu, N, Oze, T., Yakushijin, T., Mochizuki, K., Hagiwara, H., Oshita, M., Mita, E., Fukui, H., Inada, M., Tamura, S., Yoshihara, H., Hyashi, E., Inoue, A., Imai, Y., Kato, M., Miyagi, T., Hohsui, A., Ishida, M., Kiso, S., Kanto, T., KasahInoue, Y., Hiramatsu, N, Oze, T., Y
- Journal Title
  
  Journal of Viral Hepatitis (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance2009
- Author(s)
  Kurashige N, Hiramatsu N, et al.
- Journal Title
  
  J Gastroenterol. 44(8)
  
  Pages: 864-70
- NAID
  10025176735
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance2009
- Author(s)
  Kurashige, N., Ohkawa K. Hiramatsu, N., Yakushijin, T., Mochizuki, K., Oze, T., Kiso, S., Kanto, T., Takehara, T., Kasahara, A., Doi, Y., Yamada, A., Fukuda, K., Oshita, M., Mita, E., Fukui, H., Nagase, T., Yoshihara, H., Imai, Y., Kato, M., Kashihara, T. Kurashige, N
- Journal Title
  
  Journal of Gastroenterology 44
  
  Pages: 864-870
- NAID
  10025176735
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis2009
- Author(s)
  Kurokawa M, Hiramatsu N, et al.
- Journal Title
  
  Hepatol Res. 39(5)
  
  Pages: 432-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis2009
- Author(s)
  Itose, I., Kanto, T. Kakita, N., Takebe, S., Inoue, M., Higashitani, K., Miyazaki, M., Miyatake, H., Sakakibara, M., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  than those with active hepatitis. Journal of Viral Hepatitis 16
  
  Pages: 846-852
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir Antiviral Therapy2009
- Author(s)
  Kurashige N., Ohkawa, K Hiramatsu, N., Oze, T., Yakushijin, T., Mochizuki, K., Hosui, A., Miyagi, T., Ishida, H., Tatsumi, T., Kanto, T., Takehara, T., Hayashi, N.
- Journal Title
  
  14
  
  Pages: 873-877
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Effect of interferon alpha-2b plus ribavirine therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis2009
- Author(s)
  Kurokawa, M., Hiramatsu, M, et al.
- Journal Title
  
  Hepatology Research 39
  
  Pages: 432-438
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir.2009
- Author(s)
  Kurashige N, Hiramatsu N(2番目), et. al.
- Journal Title
  
  Antivir Ther 14(6)
  
  Pages: 873-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin : reducing drug doses has no impact on rapid and susutained virological responses2009
- Author(s)
  Inoue, Y., Hiramatsu, N, et al.
- Journal Title
  
  Journal of Viral Hepatitis (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Peginterferon alfa-2b affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with pegylated interferon alfa-2b plus ribavirin.2009
- Author(s)
  Oze T, Hiramatsu N(2番目), et. al.
- Journal Title
  
  J Viral Hepat 16(8)
  
  Pages: 578-85
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin2009
- Author(s)
  Hiramatsu, N., Oze, T, et al.
- Journal Title
  
  Journal of Viral Hepatitis 16
  
  Pages: 586-594
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Effect of interferon alpha-2b plus ribavirine therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis2009
- Author(s)
  Kurokawa, M., Hiramatsu, M Oze, T., Mochizuki, K., Yakushijin, T., Kurashige, N., Inoue, Y., Igura, T., Imanaka, K., Yamada, A., Oshita, M., Hagiwara, H., Mita, E., Ito, T., Inui, Y., Hijioka, T., Yoshihara, H., Inoue, A., Imai, Y., Kato, M., Kiso, S., KaKurokawa, M., Hiramatsu, M Oze, T., Mochizuki, K.
- Journal Title
  
  Hepatology Research 39
  
  Pages: 432-438
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.2009
- Author(s)
  Kurashige N, Hiramatsu N(2番目), et. al.
- Journal Title
  
  J Gastroenterol 44(8)
  
  Pages: 864-70
- NAID
  10025176735
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590777
[Journal Article] Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir2009
- Author(s)
  Kurashige N., Ohkawa, K Hiramatsu, N., Oze, T., Yakushijin, T., Mochizuki, K., Hosui, A., Miyagi, T., Ishida, H., Tatsumi, T., Kanto, T., Takehara, T., Hayashi, N.
- Journal Title
  
  Antiviral Therapy 14
  
  Pages: 873-877
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin2009
- Author(s)
  Hiramatsu, N., Oze, T Yakushijin, T., Inoue, Y., Igura, T., Mochizuki, K., Imanaka, K., Kaneko, A., Oshita, M., Hagiwara, H., Mita, E., Nagase, T., Ito, T., Inui, Y., Hijioka, T., Katayama, K., Tamura, S., Yoshihara, H., Imai, Y., Kato, M., Yoshida, Y., THiramatsu, N., Oze, T Yakushijin, T., Inoue, Y., Igura, T., Mochizuki, K., Imanaka, K
- Journal Title
  
  Journal of Viral Hepatitis 16
  
  Pages: 586-594
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virusinfection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I2008
- Author(s)
  Miyazaki M., Kanto T., Inoue, M., Itose, I., Miyatake, H., Sakakibara, M., Yakushijin, T., Kakita, N., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Medical Virology 80
  
  Pages: 980-988
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C2008
- Author(s)
  Hiramatsu N. Kurashige N, et al.
- Journal Title
  
  Hepatology Research 38
  
  Pages: 52-59
- NAID
  10020116973
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma.2008
- Author(s)
  Kohga K., Takehara T., Tatsumi, T., Ohkawa, K., Miyagi, T., Hiramatsu, N., Kanto, T., Kasugai, T., Katayama, K., Kato, M., Hayashi, N.
- Journal Title
  
  Cancer Science 99
  
  Pages: 1643-1649
- NAID
  10024010054
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.2008
- Author(s)
  Kurashige N, Hiramatsu N, Ohkawa K, et. al.
- Journal Title
  
  Hepatology Research (in press)
- NAID
  10024148320
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18599003
[Journal Article] Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virusinfection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I Journal of Medical Virology2008
- Author(s)
  Miyazaki M., Kanto T., Inoue, M., Itose, I., Miyatake, H., Sakakibara, M., Yakushijin, T., Kakita, N., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  80
  
  Pages: 980-988
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.2008
- Author(s)
  Kurashige N., Hiramatsu N. Ohkawa, K., Oze, T., Inoue, Y., Kurokawa, M., Yakushijin, T., Igura, T., Kiso, S., Kanto, T., Takehara, T., Tamura, S., Kasahara, A., Oshita, M., Hijioka, T., Katayama, K., Yoshihara, H., Hayashi, E., Imai, Y., Kato, M., Hayashi, N.
- Journal Title
  
  Hepatology Research 38
  
  Pages: 450-456
- NAID
  10024148320
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.2008
- Author(s)
  Kurashige, N., Hiramatsu, N., et. al.
- Journal Title
  
  Hepatology Research (In press)
- NAID
  10024148320
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution2008
- Author(s)
  Toyama T., Hiramatsu N. Yakushijin, T., Oze, T., Nakanishi, F., Yasumaru, M., Mochizuki, K., Kanto, T., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Clinical Gastroenterology 42
  
  Pages: 317-322
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990-20032008
- Author(s)
  Tanaka H., Imai Y. Hiramatsu N, Ito Y, Imanaka K, Oshita M, Hijioka T, Katayama K, Yabuuchi I, Yoshihara H, Inoue A, Kato M, Takehara T, Tamura S, Kasahara A, Hayashi N, Tsukuma H.
- Journal Title
  
  Annals of Internal Medicine 148
  
  Pages: 820-826
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine2008
- Author(s)
  Kurashige N., Hiramatsu N. Ohkawa, K., Oze, T., Inoue, Y., Kurokawa, M., Yakushijin, T., Igura, T., Kiso, S., Kanto, T., Takehara, T., Tamura, S., Kasahara, A., Oshita, M., Hijioka, T., Katayama, K., Yoshihara, H., Hayashi, E., Imai, Y., Kato, M., HayashiKura
- Journal Title
  
  Hepatology Research 38
  
  Pages: 450-456
- NAID
  10024148320
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] A new prognostic system for hepatocellular carcinoma including recurrent cases : a study of 861 patients in a single institution.2008
- Author(s)
  Toyama T., Hiramatsu N., et al.
- Journal Title
  
  Journal of Clinical Gastroenterology 42
  
  Pages: 317-322
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine2008
- Author(s)
  Kurashige, N, Hiramatsu, N, Ohkawa, K, et. al.
- Journal Title
  
  Hepatol Res 38
  
  Pages: 450-456
- NAID
  10024148320
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18599003
[Journal Article] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.2008
- Author(s)
  Kurashige N, Hiramatsu N, Ohkawa K, et. al.
- Journal Title
  
  Hepatology Research 38
  
  Pages: 450-6
- NAID
  10024148320
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18599003
[Journal Article] A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution.2008
- Author(s)
  Toyama T., Hiramatsu N. Yakushijin, T., Oze, T., Nakanishi, F., Yasumaru, M., Mochizuki, K., Kanto, T., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Clinical Gastroenterology 42
  
  Pages: 317-322
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.2008
- Author(s)
  Kurashige N., Hiramatsu N., et al.
- Journal Title
  
  Hepatology Research 38
  
  Pages: 450-456
- NAID
  10024148320
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities2007
- Author(s)
  Jinushi, M., Takehara, T., Tatsumi, T., Yamaguchi, S., Sakamori, R., Hiramatsu, N., Kanto, T., Ohkawa, K., Hayashi, N
- Journal Title
  
  Immunology 120
  
  Pages: 73-82
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Natural killer cell-mediated ablation of metastatic liver tumors by hydrodynamic injection of IFNα gene to mice2007
- Author(s)
  Takehara, T., Uemura, A., Tatsumi, T., Suzuki, T., Kimura, R., Shiotani, A., Ohkawa, K., Kanto, T., Hiramatsu, N., Hayashi, N
- Journal Title
  
  Int J Cancer 120
  
  Pages: 1252-1260
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18390216
[Journal Article] Innate immunity in hepatitis C virus infection: Interplay amongdendritic cells, natural killer cells and natural killer T cells2007
- Author(s)
  Jinushi, M., Takehara, T., Tatsumi, T., Yamaguchi, S., Sakamori, R., Hiramatsu, N., Kanto, T., Ohkawa, K., Hayashi, N
- Journal Title
  
  Hepatolgy Reseach 37 Suppl 3S
  
  Pages: 319-326
- NAID
  10019796655
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4+ CD25+ T cells with PD-1-dependent regulatory activities2007
- Author(s)
  Jinushi, M., Takehara, T., Tatsumi, T., Yamaguchi, S., Sakamori, R., Hiramatsu, N., Kanto, T., Ohkawa, K., Hayashi, N
- Journal Title
  
  Immunology 120
  
  Pages: 73-82
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18390216
[Journal Article] Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T cell response in chronic hepatitis C virus infection2007
- Author(s)
  Miyatake H., Kanto T., Inoue, M., Sakakibara, M., Kaimori, A., Yakushijin, T., Itose, I., Miyazaki, M., Kuzushita, N., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Viral Hepatitis 14
  
  Pages: 404-412
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-α2b and ribavirin therapy for chronic hepatitis C patients.2007
- Author(s)
  Itose I., Kanto T., Inoue, M., Miyazaki, M., Miyatake, H., Sakakibara, M., Yakushijin, T., Oze, T., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Medical Virology 79
  
  Pages: 511-521
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T cell response in chronic hepatitis C virus infection.2007
- Author(s)
  Miyatake H., Kanto T., Inoue, M., Sakakibara, M., Kaimori, A., Yakushijin, T., Itose, I., Miyazaki, M., Kuzushita, N., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  Journal of Viral Hepatitis 14
  
  Pages: 404-412
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590765
[Journal Article] Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-α2b and ribavirin therapy for chronic hepatitis C patients2007
- Author(s)
  Itose I., Kanto T., Inoue, M., Miyazaki, M., Miyatake, H., Sakakibara, M., Yakushijin, T., Oze, T., Hiramatsu, N., Takehara, T., Kasahara, A., Hayashi, N.
- Journal Title
  
  ournal of Medical Virology 79
  
  Pages: 511-521
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Natural killer cell-mediated ablation of metastatic liver tumors by hydrodynamic injection of IFNalpha gene to mice2007
- Author(s)
  Takehara T., Hiramatsu N., et al.
- Journal Title
  
  International Journal of Cancer 120
  
  Pages: 1252-1260
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities Immunology2007
- Author(s)
  Jinushi, M., Takehara, T., Tatsumi, T., Yamaguchi, S., Sakamori, R., Hiramatsu, N., Kanto, T., Ohkawa, K., Hayashi, N
- Journal Title
  
  120
  
  Pages: 73-82
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590764
[Journal Article] Early decline of hemoglobin correlates_with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.2006
- Author(s)
  Oze, T., Hiramatsu, N., et al.
- Journal Title
  
  J Gastroenterol 41
  
  Pages: 862-872
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590592
[Journal Article] Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?2006
- Author(s)
  Hiramatsu N, Takehara T, et al.
- Journal Title
  
  Hepatology Research 35
  
  Pages: 185-189
- NAID
  10018774942
- Data Source
  KAKENHI-PROJECT-18390216
[Journal Article] Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.2006
- Author(s)
  Oze, T., Hiramatsu, N.et al.
- Journal Title
  
  Journal of Gastroenterology 41
  
  Pages: 862-872
- NAID
  10020626268
- Data Source
  KAKENHI-PROJECT-16590592
[Journal Article] Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels2006
- Author(s)
  Kanto T., Hiramatsu N., et al.
- Journal Title
  
  Intervirology 49
  
  Pages: 58-63
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Early decline of hemoglobin correlates with progression of ribavirin induced hemolytic anemia during interferon plus ribavirin combination therapy in chronic hepatitis C2006
- Author(s)
  Oze T., Hiramatsu N., et al.
- Journal Title
  
  Hepatology Research 41
  
  Pages: 862-872
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Qwick generation of fully mature denritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhnacers2006
- Author(s)
  Sakakibara M., Hiramatsu N., et al.
- Journal Title
  
  Journal of Immunotherapy 29
  
  Pages: 67-77
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?2006
- Author(s)
  Hiramatsu N., Oze T., et al.
- Journal Title
  
  Hepatology Research 35
  
  Pages: 185-189
- NAID
  10018774942
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590592
[Journal Article] Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection2006
- Author(s)
  Yakushijin T, Kanto T, Inoue M, Oze T, Miyazaki M, Itose I, Miyatake H, Sakakibara M, Kuzushita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
- Journal Title
  
  Hepatol Res. 34
  
  Pages: 156-162
- NAID
  10020405278
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] IL-13 in chronic hepatitis C infection2006
- Author(s)
  Inoue M., Hiramatsu N., et al.
- Journal Title
  
  Journal of Hepatology 45
  
  Pages: 190-196
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?2006
- Author(s)
  Hiramatsu N, Oze T, Tsuda N, Kurashige N, Koga K, Toyama T, Yasumaru M, Kanto T, Takehara T, Kasahara A, Kato M, Yoshihara H, Katayama K, Hijioka T, Hagiwara H, Kubota S, Oshita M, Haruna Y, Mita E, Suzuki K, Ishibashi K, Hayashi N.
- Journal Title
  
  Hepatol.Res. 35
  
  Pages: 185-189
- NAID
  10018774942
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Should aged patients with chronic hepatic C be treated with interferon and ribavirin combination therapy?2006
- Author(s)
  Hiramatsu N., et al.
- Journal Title
  
  Hepatology Research 35
  
  Pages: 185-189
- NAID
  10018774942
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.2006
- Author(s)
  Oze T, Hiramatsu N, Kurashige N, Tsuda N, Yakushijin T, Kanto T, Takehara T, Kasahara A, Kato M, Yoshihara H, Katayama K, Kubota S, Hijioka T, Ishibashi K, Oshita M, Hagiwara H, Haruna Y, Mita E, Tamura S, Hayashi N.
- Journal Title
  
  J.Gastroenterol. 41
  
  Pages: 862-872
- NAID
  10020626268
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?2006
- Author(s)
  Hiramatsu, N., Oze, T., et al.
- Journal Title
  
  Hepatology Research 35
  
  Pages: 185-189
- NAID
  10018774942
- Data Source
  KAKENHI-PROJECT-16590592
[Journal Article] Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?2006
- Author(s)
  Hiramatsu, N., Oze, T., et al.
- Journal Title
  
  Hepatol Res 35
  
  Pages: 185-189
- NAID
  10018774942
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590592
[Journal Article] Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.2006
- Author(s)
  Oze T., Hiramatsu N., et al.
- Journal Title
  
  Journal of Gastroenterology 41
  
  Pages: 862-872
- NAID
  10020626268
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590592
[Journal Article] Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection2006
- Author(s)
  Yakushijin T., Hiramatsu N., et al.
- Journal Title
  
  Hepatology Research 34
  
  Pages: 156-162
- NAID
  10020405278
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?2006
- Author(s)
  Hiramatsu N, Hayashi N, et al.
- Journal Title
  
  Hepatoloay Research 35
  
  Pages: 185-189
- NAID
  10018774942
- Data Source
  KAKENHI-PROJECT-15109006
[Journal Article] Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.2005
- Author(s)
  Jinushi M, Hiramatsu N
- Journal Title
  
  Journal of Hepatology 43
  
  Pages: 1013-1020
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Alteration in gene expression profile by full-length hepatitis B genome2005
- Author(s)
  Nakanishi F., Hiramatsu N., et al.
- Journal Title
  
  Intervirology 48
  
  Pages: 77-83
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinoma2005
- Author(s)
  Jinushi M., Hiramatsu N., et al.
- Journal Title
  
  Journal of Hepatology 43
  
  Pages: 1013-1020
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinoma.2005
- Author(s)
  Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, Hayashi N.
- Journal Title
  
  J.Hepatol. 43
  
  Pages: 1013-1020
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590640
[Journal Article] Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection2004
- Author(s)
  Kanto, T, Inoue, M, Miyatake, H, Sato, A, Sakakibara, M, Yakushijin, T, Oki, C, Itose, I, Hiramatsu, N, Takehara, T, Kasahara, A, Hayashi, N
- Journal Title
  
  J Infect Dis 190
  
  Pages: 1919-1926
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15109006
[Journal Article] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan.2004
- Author(s)
  Hiramatsu N, et al.
- Journal Title
  
  Hepatol Res 29
  
  Pages: 142-147
- NAID
  10018024528
- Data Source
  KAKENHI-PROJECT-15109006
[Journal Article] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan.2004
- Author(s)
  Hiramatsu, N., Kasahara, A., et al.
- Journal Title
  
  Hepatol Res 29
  
  Pages: 142-147
- NAID
  10018024528
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590592
[Journal Article] Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.2004
- Author(s)
  Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T, Kanazawa Y, Hiramatsu N, Hayashi N.
- Journal Title
  
  J Immunol 173
  
  Pages: 6072-6081
- Data Source
  KAKENHI-PROJECT-15109006
[Journal Article] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan.2004
- Author(s)
  Hiramatsu N., Kasahara A., et al.
- Journal Title
  
  Hepatology Research 29
  
  Pages: 142-147
- NAID
  10018024528
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590592
[Presentation] C型慢性肝炎におけるダクラタスビル・アスナプレビル併用療法の治療成績ならびに薬剤耐性変異の解析2016
- Author(s)
  森下直紀、平松直樹、小瀬嗣子、竹原徹郎
- Organizer
  日本肝臓学会総会
- Place of Presentation
  千葉
- Year and Date
  2016-05-20
- Data Source
  KAKENHI-PROJECT-25460994
[Presentation] 難治性C型肝炎に対するTelaprevir/Peg-IFN/RBV3剤併用療法における治療効果ならびに副反応に関与する因子について ―多施設(OLF)共同研究―2013
- Author(s)
  平松直樹、林　紀夫、竹原徹郎．
- Organizer
  第49回日本肝臓学会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-25460994
[Presentation] 難治性C型肝炎に対するTVR/Peg-IFN/RBV併用療法ならびに Simeprevir(TMC435)/Peg-IFN/RBV併用療法の有効性と安全性について2013
- Author(s)
  平松直樹、竹原徹郎、林　紀夫．
- Organizer
  第17回日本肝臓学会大会、第55回日本消化器病学会大会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-25460994
[Presentation] TIE2-expressing monocytes are feasible angiogenesis-related cellular diagnostics for hepatocellular carcinoma: Involvement of inflammatory cytokines in the generation2012
- Author(s)
  Matsubara T, Kanto T, Kuroda S, Yoshio S, Higashitani K, Miyazaki M, Hiramatsu N, Kasahara A, Takehara T
- Organizer
  The Liver Meeting AASLD 63rd Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Year and Date
  2012-11-10
- Data Source
  KAKENHI-PROJECT-22590729
[Presentation] Pro-angiogenic receptor TIE2-expressing monocytes/TEM as novel diagnostic biomarker for hepatocellular carcinoma2012
- Author(s)
  Matsubara T, Kanto T, Kuroda S, Yoshio S, Higashitani K, Kakita N, Miyazaki M, Hiramatsu N, Kasahara A, Takehara T.
- Organizer
  The Liver Meeting AASLD 62nd Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Year and Date
  2012-11-10
- Data Source
  KAKENHI-PROJECT-22590729
[Presentation] Association of indoleamine 2,3-dioxygenase in dendritic cells with the generation ofregulatory T cells in chronic hepatitis C patients2012
- Author(s)
  Higashitani K, Kanto T, Kuroda S, Yoshio S, Matsubara T, Kakita N, Oze T, Hiramatsu N, Mita E, Imai Y, Kasahara A, Okuno A, Takikawa O, Hayashi N, Takehara T
- Organizer
  The Liver Meeting AASLD 63rd Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Year and Date
  2012-11-10
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] Enhanced ability of IL28A and IL28B induction in plasmacytoid dendritic cells in chronic hepatitis C patients with major allele of IL28B single nucleotide polymorphism.2011
- Author(s)
  Kakita N, Kanto T, Miyazaki M, Yoshio S, Kuroda S, Matsubara T, Higashitani K, Sakakibara M, Hiramatsu N, Kasahara S, Takehara T, Hayashi N
- Organizer
  The Liver Meeting AASLD 62nd Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco CA, USA
- Year and Date
  2011-11-07
- Data Source
  KAKENHI-PROJECT-22590729
[Presentation] Pro-angiogenic receptor TIE2-expressing monocytes/TEM as novel diagnostic biomarker for hepatocellular carcinoma2011
- Author(s)
  Matsubara T, Kanto T, Kuroda S, Yoshio S, Higashitani K, Kakita N, Miyazaki M, Hiramatsu N, Kasahara A, Takehara T
- Organizer
  The Liver Meeting AASLD 62nd Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco CA, USA
- Year and Date
  2011-11-07
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] Enhanced ability of IL28A and IL28B induction in plasmacytoid dendritic cells in chronic hepatitis C patients with major allele of IL28B single nucleotide polymorphism.2011
- Author(s)
  Kakita N, Kanto T, Miyazaki M, Yoshio S, Kuroda S, Matsubara T, Higashitani K, Sakakibara M, Hiramatsu N, Kasahara A, Takehara T, Hayashi N
- Organizer
  The Liver Meeting AASLD 62nd Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco CA, USA
- Year and Date
  2011-11-08
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] Viral suppression at week 4 exceeds the IL28B SNP for predicting SVR in pegylated interferon plus ribavirin combination therapy of genotype 1 infected patients with chronic hepatitis.2011
- Author(s)
  Oze T, Hiramatsu N, Yakushijin T, Doi Y, Ogawa H, Hagiwara H, Mita E, Kaneko A, Katayama K, Hijioka T, Tamura S, Yoshihara H, Inoue A, Imai Y, Hayashi E, Hosui A, Miyagi T, Yoshida Y, Tatsumi T, Kiso S, Kanto T, Kasahara A, Hayashi N, Takehara T
- Organizer
  The Liver Meeting AASLD 62nd Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco CA
- Year and Date
  2011-11-07
- Data Source
  KAKENHI-PROJECT-22590729
[Presentation] Viral suppression at week 4 exceeds the IL28B SNP for predicting SVR in pegylated interferon plus ribavirin combination therapy of genotype 1 infected patients with chronic hepatitis.2011
- Author(s)
  Oze T, Hiramatsu N, Yakushijin T, Doi Y, Ogawa H, Hagiwara H, Mita E, Kaneko A, Katayama K, Hijioka T, Tamura S, Yoshihara H, Inoue A, Imai Y, Hayashi E, Hosui A, Miyagi T, Yoshida Y, Tatsumi T, Kiso S, Kanto T, Kasahara A, Hayashi N, Takehara T.
- Organizer
  The Liver Meeting AASLD 62nd Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco CA, USA
- Year and Date
  2011-11-06
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] Viral suppression at week 4 exceeds the IL28B SNP for predicting SVR in pegylated interferon plus ribavirin combination therapy of genotype 1 infected patients with chronic hepatitis C2011
- Author(s)
  Oze T, Hiramatsu N, et al
- Organizer
  The Liver Meeting AASLD 62d Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco, CA, USA
- Year and Date
  2011-11-06
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] Estimation of liver fibrosis by VTTQ (Virtual tissue touch quantification in chronic liver disease: the usefulness of VS/PLT2011
- Author(s)
  Yamada R, Hiramatsu N, Oze T, Harada N, Song C, Inoue Y, Kurokawa M, Miyazaki M, Yakushijin T, Hosui A, Miyagi T, Tatsumi T, Kiso S, Kanto T, Kasahara A, Hayashi N, Takehara T
- Organizer
  The Liver Meeting AASLD 62nd Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco CA, USA
- Year and Date
  2011-11-06
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] Estimation of liver fibrosis by VTTQ (virtual tissue touch quantification) in chronic liver disease : The usefulness of Vs/plt2011
- Author(s)
  Yamada R, Hiramatsu N, et al
- Organizer
  The Liver Meeting AASLD 62d Annual Meeting and Postgraduate Course
- Place of Presentation
  San Francisco, CA, USA
- Year and Date
  2011-11-06
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] 難治性C型肝炎に対するPeg-IFN/Ribavirin併用療法の個別化治療による治療効果改善の可能性"シンポジウム「C型肝炎における抗ウイルス療法の近未来」2010
- Author(s)
  平松直樹
- Organizer
  第46回日本肝臓学会総会
- Place of Presentation
  ホテルメトロポリタン山形
- Year and Date
  2010-05-27
- Data Source
  KAKENHI-PROJECT-20590777
[Presentation] Active role of tryptophan catalyzing enzyme, indoleamine 2, 3-dioxygenase, in the generation of regulatory T cells in chronic hepatitis C patients2010
- Author(s)
  Higashitani K, Kanto T, Miyazaki M, Inoue M, Matsubara T, Kakita N, Itose I, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N
- Organizer
  The Liver Meeting AASLD 61stAnnual Meeting and Postgraduate Course
- Place of Presentation
  Boston MA
- Year and Date
  2010-10-30
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] 難治性C型肝炎に対する新薬開発を踏まえたPeg-IFN/Ribavirin併用療法の適応と限界"パネルディスカッション「C型肝炎に対する新たな治療戦略」、JDDW20102010
- Author(s)
  平松直樹
- Organizer
  第18回日本消化器関連学会週間
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2010-10-13
- Data Source
  KAKENHI-PROJECT-20590777
[Presentation] Indoleamine 2, 3-dioxygenase as an active inducer of regulatory T cells in chronic HCV infection2010
- Author(s)
  Higashitani K, Kanto T, Miyazaki M, Inoue M, Matsubara T, Kakita N, Itose I, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N
- Organizer
  17thInternational Meeting on Hepatitis C virus and related viruses
- Place of Presentation
  Yokohama Japan
- Year and Date
  2010-09-11
- Data Source
  KAKENHI-PROJECT-22590730
[Presentation] Distinctive roles of IL-10-producing Type 1 regulatory T cells (Tr1) in the pathogenesis of hepatitis C virus-infected hepatocellular carcinoma2010
- Author(s)
  Kakita N, Kanto T, Matsubara T, Higashitani K, Miyazaki M, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N
- Organizer
  The Liver Meeting AASLD 61stAnnual Meeting and Postgraduate Course
- Place of Presentation
  Boston MA, USA
- Year and Date
  2010-10-30
- Data Source
  KAKENHI-PROJECT-22590729
[Presentation] "難治性C型肝炎に対する新薬開発を踏まえたPeg-IFN/Ribavirin併用療法の適応と限界"パネルディスカッション「C型肝炎に対する新たな治療戦略」2010
- Author(s)
  平松直樹
- Organizer
  JDDW2010(第18回日本消化器関連学会週間)
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2010-10-14
- Data Source
  KAKENHI-PROJECT-20590777
[Presentation] Pro-angiogenic receptor TIE2-expressing monocytes/ TEMs as novel diagnostic biomarker for hepatocellular carcinoma.2010
- Author(s)
  Matsubara T, Kanto T, Higashitani K, Kakita N, Miyazaki M, Inoue M, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
- Organizer
  The Liver Meeting AASLD 61stAnnual Meeting and Postgraduate Course
- Place of Presentation
  Boston MA, USA
- Year and Date
  2010-10-30
- Data Source
  KAKENHI-PROJECT-22590729
[Presentation] "難治性C型肝炎に対するPeg-IFN/Ribavirin併用療法の個別化治療による治療効果改善の可能性"シンポジウム「C型肝炎における抗ウイルス療法の近未来」2010
- Author(s)
  平松直樹
- Organizer
  第46回日本肝臓学会総会
- Place of Presentation
  ホテルメトロポリタン山形
- Year and Date
  2010-05-27
- Data Source
  KAKENHI-PROJECT-20590777
[Presentation] Prediction of early response to pegylated interferon and ribavirin in chronic hepatitis C based on amino acid substitutions in the viral core region2009
- Author(s)
  Inoue Y, Hiramatsu N, et al.
- Organizer
  The American Association for the Study of Liver Diseases 60^<th> Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston MA, USA
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Prediction of early response to pegylated interferon and ribavirin in chronic hepatitis C based on amino acid substitutions in the viral core region2009
- Author(s)
  Inoue Y, Hiramatsu N
- Organizer
  The Liver Meeting AASLD 60th Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] C型慢性肝炎に対するpeg-IFN+RBV併用無効例に対する方策難治性C型肝炎に対するPeg-IFN/RBV併用療法における非著効例への方策多施設(OLF)共同研究(会議録)2009
- Author(s)
  小瀬嗣子, 平松直樹
- Organizer
  第13回日本肝臓学会大会
- Place of Presentation
  国立京都国際会館
- Year and Date
  2009-10-15
- Data Source
  KAKENHI-PROJECT-20590777
[Presentation] Prediction of early response to pegylated interferon and ribavirin in chronic hepatitis C based on amino acid substitutions in the viral core region.2009
- Author(s)
  Inoue Y, Hiramatsu N, et. al.
- Organizer
  The Liver Meeting AASLD 60th Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Data Source
  KAKENHI-PROJECT-19590765
[Presentation] C型肝炎に対する治療方針のコンセンサス2009
- Author(s)
  平松直樹
- Organizer
  第45回日本肝臓学会総会
- Place of Presentation
  神戸国際会議場
- Year and Date
  2009-06-05
- Data Source
  KAKENHI-PROJECT-20590777
[Presentation] Reduced drug doses in genotype 1 patients with chronic hepatitis C during treatment with pegylated interferon alfa-2B plus ribavirin delays the timing of HCVRNA negativity or prevents its attainment ; A propensity score-matched study2009
- Author(s)
  Son C, Hiramatsu N, et al.
- Organizer
  The American Association for the Study of Liver Diseases 60^<th> Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston MA, USA
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] C型慢性肝炎に対するpeg-IFN+RBV併用無効例に対する方策難治性C型肝炎に対するPeg-IFN/RBV併用療法における非著効例への方策多施設 (OLF) 共同研究 (会議録)2009
- Author(s)
  小瀬嗣子, 平松直樹
- Organizer
  第13回日本肝臓学会大会
- Place of Presentation
  国立京都国際会館
- Year and Date
  2009-10-15
- Data Source
  KAKENHI-PROJECT-20590777
[Presentation] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alfa-2B and ribavirin : reducing drug doses has no impact on rapid and sustained virological responses2009
- Author(s)
  Inoue Y, Hiramatsu N., et al.
- Organizer
  The American Association for the Study of Liver Diseases 60^<th> Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston MA, USA
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Reduced drug doses in genotype 1 patients with chronic hepatitis C during treatment with pegylated interferon alfa-2B plus ribavirin delays the timing of HCVRNA negativity or prevents its attainment; A propensity score-matched study.2009
- Author(s)
  Son C, Hiramatsu N, et. al.
- Organizer
  The Liver Meeting AASLD 60th Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Data Source
  KAKENHI-PROJECT-19590765
[Presentation] Reduced drug doses in genotype 1 patients with chronic hepatitis C during treatment with pegylated interferon alfa-2B plus ribavirin delays the timing of HCVRNA negativity or prevents its attainment; A propensity score-matched study2009
- Author(s)
  Son C, Hiramatsu N
- Organizer
  he Liver Meeting AASLD 60th Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alfa-2B and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses2009
- Author(s)
  Inoue Y, Hiramatsu N
- Organizer
  The Liver Meeting AASLD 60th Annual Meeting and Postgraduate Course
- Place of Presentation
  Boston, MA, USA
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Ribavirin dosage reduction raises relapse rate dose-dependently in genotype 1 patients with chronic hepatitis C responding to pegylated interferon alfa-2b plus ribavirin2008
- Author(s)
  Oze T., Hiramatsu N., et al
- Organizer
  The 59^<th> Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  San Francisco, CA. USA
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Extended treatment with peginterferon alfa-2b and ribavirin combination therapy can suppress the relapse rate after treatment of chronic hepatitis C genotype 1 patients with late viral relapse2008
- Author(s)
  Oze T., Hiramatsu N
- Organizer
  The 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  San Francisco, CA. USA
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Effect of interferon alfa-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis2008
- Author(s)
  Kurokawa M., Hiramatsu N
- Organizer
  The 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  San Francisco, CA. USA
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Ribavirin dosage reduction raises relapse rate dose-dependently in genotype 1 patients with chronic hepatitis C responding to pegylated interferon alfa-2b plus ribavirin2008
- Author(s)
  Oze T., Hiramatsu N
- Organizer
  The 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  San Francisco, CA. USA
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Effect of interferon alfa-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis2008
- Author(s)
  Kurokawa M., Hiramatsu N., et al
- Organizer
  The 59^<th> Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  San Francisco, CA. USA
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Extended treatment with peginterferon alfa-2b and ribavirin combination therapy can suppress the relapse rate after treatment of chronic hepatitis C genotype 1 patients with late viral relapse2008
- Author(s)
  Oze T., Hiramatsu N., et al
- Organizer
  The 59^<th> Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  San Francisco, CA. USA
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590764
[Presentation] Regulation of the NKG2D immunoreceptor by soluble MICA during transcatheter arterial embolization for hepatocellular carcinoma2007
- Author(s)
  Kohga, K., Takehara, T., Hikita, H., Sasakawa, A., Uemura, A., Sakamori, R., Yamaguchi, S., Tatsumi, T., Ohkawa, K., Kanto, T., Hiramatsu, N., Katayama, K., Kato, M., Hayashi, N
- Organizer
  The American Association for the Study of Liver Diseases The 58th Annual Meeting AASLD
- Place of Presentation
  Hynes Convention Center, Boston, MA, USA
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18390216
[Presentation] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in hepatitis B patients treated with lamivudine2006
- Author(s)
  Kurashige, N, Hiramatsu, N, Ohkawa, K, et. al.
- Organizer
  The 57th annual meeting of the American Association of the Study of Liver Diseases
- Place of Presentation
  Boston, USA
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18599003
[Presentation] Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.2006
- Author(s)
  Kurashige N, Hiramatsu N, Ohkawa K, et. al.
- Organizer
  57th meeting of the American Association of the Study of Liver Diseases.
- Place of Presentation
  Boston
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18599003
[Presentation] TVR/Peg-IFN/RBV併用療法におけるTVR投与量が与える治療効果ならびに副作用へのインパクト
- Author(s)
  平松直樹、林　紀夫、竹原徹郎．
- Organizer
  第100回日本消化器病学会総会
- Place of Presentation
  東京
- Year and Date
  2014-04-23 – 2014-04-26
- Data Source
  KAKENHI-PROJECT-25460994
[Presentation] 難治性C型肝炎に対するSMV/Peg-IFN/RBV併用療法の有用性について
- Author(s)
  竹原徹郎、平松直樹、林　紀夫．
- Organizer
  第50回日本肝臓学会総会
- Place of Presentation
  東京
- Year and Date
  2014-04-29 – 2014-04-30
- Data Source
  KAKENHI-PROJECT-25460994
[Presentation] エンテカビル投与中のB型慢性肝疾患症例における治療開始後AFP値の肝発癌リスクへの影響－多施設共同研究－
- Author(s)
  山田涼子、平松直樹、竹原徹郎．
- Organizer
  第18回日本肝臓学会大会
- Place of Presentation
  神戸
- Year and Date
  2014-10-23 – 2014-10-24
- Data Source
  KAKENHI-PROJECT-25460994

1. TAKEHARA Tetsuo (70335355)

# of Collaborated Projects: 8 results

# of Collaborated Products: 36 results
2. KANTO Tatsuya (80372613)

# of Collaborated Projects: 6 results

# of Collaborated Products: 55 results
3. TATSUMI Tomonide (20397699)

# of Collaborated Projects: 3 results

# of Collaborated Products: 9 results
4. KASAHARA Akinori (70214286)

# of Collaborated Projects: 2 results

# of Collaborated Products: 20 results
5. MATSUMOTO Hitoshi (80467505)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
6. OHKAWA Kazuyoshi (80432540)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
7. MIYOSHI Eiji (20322183)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. OZE tsugiko (30623582)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
9. HAYASHI Norio (00144478)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
10. TOYAMA Takashi

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 石田永

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 中西文彦

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. KAZUMOTO Murata

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. SUGIYAMA Masasya

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
15. HIKITA Hayato

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. TANAKA Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. MIYAGI Takuya

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
18. YOSHIDA Yuuichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
19. NAWA Takatoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
20. AONO Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
21. 溝上雅史

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. 清水聡

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

HIRAMATSU Naoki 平松 直樹

Research Projects

Research Products

Co-Researchers

The relationship between the efficacy and the prevalence of the mutant virus for the novel anti-viral drugs for hepatitis CPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of NASH pathophysiology using glycobiological techniquePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

CTL immuno-monitoring in chronic hepatitis CPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Risk factors for hepatocellular carcinoma in hepatitis C patients with normal ALT treated with pegylated interferon and ribavirin2014

Author(s)

Journal Title

HIRAMATSU Naoki 平松直樹